Vetr's Top Raters Bullish On Juno Therapeutics By: Benzinga via Benzinga March 11, 2016 at 16:07 PM EST Shares of Juno Therapeutics Inc (NASDAQ: JUNO) are down more than 9 percent year-to-date, having underperformed the Nasdaq 100 and ... Read More >>